Scientists have identified two non-retinoid compounds that may be able to treat retinitis pigmentosa (RP), a group of inherited eye diseases that cause blindness. The compounds were discovered by ...

Treatment with bioavailable small-molecule pharmacochaperones targeting the visual receptor rhodopsin offers a promising approach to prevent retinal photoreceptor degeneration caused by inherited ...

Researchers have revealed the impact of native lipids on rhodopsin signaling and regeneration, which may usher in a new paradigm for discovery of drugs that target G protein-coupled receptors (GPCRs).

Considering the lipids ejected with rhodopsin from the membrane fragments in the mass spectrometer, researchers were able to demonstrate that opsin can be regenerated in the membranes through ...

First off, my name is a misnomer. I love physics like Lennie likes bunnies. So I was wondering today about the following: What happens to the photons that hit your eye and are recognized as light? The ...

Photoreceptor cells in our eyes can adjust to both weak and strong light levels, but we still don't know exactly how they do it. Emeritus Professor Fumio Hayashi of Kobe University and his colleagues ...

Scientists say that new experiments with mouse eye tissues strongly suggest that a longstanding 'textbook concept' about the way a mammal's retina processes light needs a rewrite. Johns Hopkins ...

In a new study at University of California, Irvine, researchers have revealed the impact of native lipids on rhodopsin signaling and regeneration, which may usher in a new paradigm for discovery of ...

A newly developed light-sensing protein called the MCO1 opsin restores vision in blind mice when attached to retina bipolar cells using gene therapy, according to The National Eye Institute, which ...

Irvine, Calif., April 6, 2022 — In a new study at University of California, Irvine, researchers have revealed the impact of native lipids on rhodopsin signaling and regeneration, which may usher in a ...